MedPath

Positive Skin Test Control - Histamine

Histamine 366140-H05 Initial Upload to Intagras SPL Portal

Approved
Approval ID

5c20f3f4-65f8-4cdb-bdd1-5774da1c551b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2023

Manufacturers
FDA

Jubilant HollisterStier LLC

DUNS: 069263643

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Histamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65044-9998
Application NumberBLA103891
Product Classification
M
Marketing Category
C73585
G
Generic Name
Histamine
Product Specifications
Route of AdministrationPERCUTANEOUS
Effective DateNovember 1, 2023
FDA Product Classification

INGREDIENTS (4)

HISTAMINEActive
Quantity: 6 mg in 1 mL
Code: 820484N8I3
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.